The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
11 hedge funds and large institutions have $7.67M invested in The Oncology Institute Warrant in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.05% more ownership
Funds ownership: 4.53% → 4.58% (+0.05%)
8% less funds holding
Funds holding: 12 → 11 (-1)
31% less capital invested
Capital invested by funds: $11.2M → $7.67M (-$3.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$159K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$24.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$920 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$87.2K |
| 2 |
JG
Jefferies Group
New York
|
-$55.4K |
| 3 |
DCM
Difesa Capital Management
New York
|
-$8.3K |
TOIIW Hedge Fund Activity: Q2 2022 in Review
11 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q2 2022, worth a combined $7.67M — down 31% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TOIIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was LMR Partners, adding an estimated $159K. The largest seller was Man Group, exiting entirely with an estimated $87.2K sold.
- 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q2 2022, down from 12 in Q1 2022.
- Funds reported $7.67M of The Oncology Institute Warrant stock for Q2 2022, down 31% quarter-over-quarter.
- 0 funds opened new The Oncology Institute Warrant positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest The Oncology Institute Warrant buyer in Q2 2022 was LMR Partners, an estimated $159K added.
- The largest The Oncology Institute Warrant seller in Q2 2022 was Man Group, an estimated $87.2K sold.
Based on aggregated 13F filings for Q2 2022.